HEALEY ALS Platform Trial - Regimen D Pridopidine

PHASE2/PHASE3CompletedINTERVENTIONAL

Enrollment

163

Participants

Timeline

Start Date

December 18, 2020

Primary Completion Date

July 14, 2022

Study Completion Date

July 14, 2022

Conditions

Amyotrophic Lateral Sclerosis

Interventions

DRUG

Pridopidine

"Administration: Oral~Dose: 45mg twice daily"

DRUG

Matching Placebo

"Administration: Oral~Dose: one capsule twice daily"

Trial Locations (1)

Healey Center for ALS at Mass General, Boston